MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration
- 2 December 2003
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 185 (1) , 47-62
- https://doi.org/10.1016/j.expneurol.2003.09.014
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's diseasePublished by Elsevier ,2001
- Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis ratNeuroReport, 2001
- Experimental models of Parkinson's diseaseNature Reviews Neuroscience, 2001
- Replicating Huntington's disease phenotype in experimental animalsProgress in Neurobiology, 1999
- Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease MutationJournal of Neuroscience, 1999
- Partial Inhibition of Brain Succinate Dehydrogenase by 3‐Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in RatJournal of Neurochemistry, 1998
- 3‐Nitropropionic Acid Neurotoxicity Is Attenuated in Copper/Zinc Superoxide Dismutase Transgenic MiceJournal of Neurochemistry, 1995
- MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levelsSynapse, 1994
- Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophyJournal of the Neurological Sciences, 1994
- Nigrostriatal pathway modulates striatum vulnerability to quinolinic acidNeuroscience Letters, 1991